{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T15:27:10Z","timestamp":1794670030391,"version":"4.9.1"},"reference-count":55,"publisher":"American Society of Hematology","issue":"26","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,12,24]]},"abstract":"<jats:title>Key Points<\/jats:title><jats:p>CB T cells mediate enhanced antitumor responses compared with PB T cells in a murine model of B-cell lymphoma. The antitumor activity correlates with increased tumor-homing of CCR7high CB CD8+ T cells and rapid gain of cytotoxic and Th1 function.<\/jats:p>","DOI":"10.1182\/blood-2015-06-654780","type":"journal-article","created":{"date-parts":[[2015,10,9]],"date-time":"2015-10-09T03:04:29Z","timestamp":1444359869000},"page":"2882-2891","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":104,"title":["Cord blood T cells mediate enhanced antitumor effects compared with adult peripheral blood T cells"],"prefix":"10.1182","volume":"126","author":[{"given":"Prashant","family":"Hiwarkar","sequence":"first","affiliation":[{"name":"Molecular and Cellular Immunology Section, University College London Institute of Child Health, London, United Kingdom;"},{"name":"Department of Haematology and Bone Marrow transplantation, Birmingham Children\u2019s Hospital, Birmingham, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waseem","family":"Qasim","sequence":"additional","affiliation":[{"name":"Molecular and Cellular Immunology Section, University College London Institute of Child Health, London, United Kingdom;"},{"name":"Department of Immunology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Ricciardelli","sequence":"additional","affiliation":[{"name":"Molecular and Cellular Immunology Section, University College London Institute of Child Health, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Gilmour","sequence":"additional","affiliation":[{"name":"Laboratory Immunology, Great Ormond Street Hospital for Children, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Quezada","sequence":"additional","affiliation":[{"name":"Department of Haematology, University College London Cancer Institute, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Saudemont","sequence":"additional","affiliation":[{"name":"Anthony Nolan Research Institute, London, United Kingdom;"},{"name":"Cancer Institute, University College London, London, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Persis","family":"Amrolia","sequence":"additional","affiliation":[{"name":"Molecular and Cellular Immunology Section, University College London Institute of Child Health, London, United Kingdom;"},{"name":"Department of Bone Marrow Transplantation, Great Ormond Street Hospital for Children, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Veys","sequence":"additional","affiliation":[{"name":"Molecular and Cellular Immunology Section, University College London Institute of Child Health, London, United Kingdom;"},{"name":"Department of Bone Marrow Transplantation, Great Ormond Street Hospital for Children, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"22","key":"2019111902172485800_B1","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM199811263392201","article-title":"Outcomes among 562 recipients of placental-blood transplants from unrelated donors.","volume":"339","author":"Rubinstein","year":"1998","journal-title":"N Engl J Med"},{"issue":"10","key":"2019111902172485800_B2","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/blood.V97.10.2962","article-title":"Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia.","volume":"97","author":"Rocha","year":"2001","journal-title":"Blood"},{"issue":"1","key":"2019111902172485800_B3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2249.2005.02799.x","article-title":"T cell-mediated immune responses in human newborns: ready to learn?","volume":"141","author":"Marchant","year":"2005","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"2019111902172485800_B4","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.4049\/jimmunol.168.6.2820","article-title":"Differential patterns of methylation of the IFN-gamma promoter at CpG and non-CpG sites underlie differences in IFN-gamma gene expression between human neonatal and adult CD45RO- T cells.","volume":"168","author":"White","year":"2002","journal-title":"J Immunol"},{"issue":"3625","key":"2019111902172485800_B5","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1126\/science.144.3625.1423","article-title":"Ontogeny of the immune response.","volume":"144","author":"Silverstein","year":"1964","journal-title":"Science"},{"key":"2019111902172485800_B6","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1084\/jem.119.6.955","article-title":"Fetal response to antigenic stimulus. IV. Rejection of skin homografts by the fetal lamb.","volume":"119","author":"Silverstein","year":"1964","journal-title":"J Exp Med"},{"issue":"6","key":"2019111902172485800_B7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJM199708073370602","article-title":"Outcome of cord-blood transplantation from related and unrelated donors.","volume":"337","author":"Gluckman","year":"1997","journal-title":"N Engl J Med"},{"issue":"8","key":"2019111902172485800_B8","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1182\/blood-2006-03-011791","article-title":"Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation.","volume":"108","author":"Brunstein","year":"2006","journal-title":"Blood"},{"issue":"1","key":"2019111902172485800_B9","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1182\/blood-2013-05-502385","article-title":"Impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune reconstitution and clinical outcome.","volume":"123","author":"Lindemans","year":"2014","journal-title":"Blood"},{"issue":"5","key":"2019111902172485800_B10","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1016\/S2352-3026(15)00045-9","article-title":"Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis.","volume":"2","author":"Admiraal","year":"2015","journal-title":"Lancet Haematol"},{"issue":"5","key":"2019111902172485800_B11","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1365-2141.2011.08994.x","article-title":"Omission of in vivo T-cell depletion promotes rapid expansion of na\u00efve CD4+ cord blood lymphocytes and restores adaptive immunity within 2 months after unrelated cord blood transplant.","volume":"156","author":"Chiesa","year":"2012","journal-title":"Br J Haematol"},{"issue":"9577","key":"2019111902172485800_B12","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/S0140-6736(07)60915-5","article-title":"Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study.","volume":"369","author":"Eapen","year":"2007","journal-title":"Lancet"},{"issue":"4","key":"2019111902172485800_B13","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bbmt.2014.12.023","article-title":"Comparison of conditioning regimens with or without antithymocyte globulin for unrelated cord blood transplantation in children with high-risk or advanced hematological malignancies.","volume":"21","author":"Zheng","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"18","key":"2019111902172485800_B14","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1405584","article-title":"One-unit versus two-unit cord-blood transplantation for hematologic cancers.","volume":"371","author":"Wagner","year":"2014","journal-title":"N Engl J Med"},{"issue":"2","key":"2019111902172485800_B15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1182\/blood-2011-03-344853","article-title":"Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts.","volume":"118","author":"Brunstein","year":"2011","journal-title":"Blood"},{"issue":"3","key":"2019111902172485800_B16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/bjh.13136","article-title":"Results of a prospective multicentre myeloablative double-unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasia.","volume":"168","author":"Barker","year":"2015","journal-title":"Br J Haematol"},{"issue":"7","key":"2019111902172485800_B17","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1182\/blood.V99.7.2592","article-title":"Infusion of autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication.","volume":"99","author":"Comoli","year":"2002","journal-title":"Blood"},{"issue":"7","key":"2019111902172485800_B18","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1182\/blood-2006-11-059139","article-title":"Epstein Barr virus specific cytotoxic T lymphocytes expressing the anti-CD30zeta artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease.","volume":"110","author":"Savoldo","year":"2007","journal-title":"Blood"},{"issue":"12","key":"2019111902172485800_B19","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/cyto.a.20815","article-title":"The importance of Foxp3 antibody and fixation\/permeabilization buffer combinations in identifying CD4+CD25+Foxp3+ regulatory T cells.","volume":"75","author":"Law","year":"2009","journal-title":"Cytometry A"},{"issue":"1-2","key":"2019111902172485800_B20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jim.2007.01.012","article-title":"Quantifying tumour-infiltrating lymphocyte subsets: a practical immuno-histochemical method.","volume":"321","author":"Loughlin","year":"2007","journal-title":"J Immunol Methods"},{"issue":"1","key":"2019111902172485800_B21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1365-2249.2009.03933.x","article-title":"Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex.","volume":"157","author":"King","year":"2009","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"2019111902172485800_B22","doi-asserted-by":"crossref","first-page":"e44219","DOI":"10.1371\/journal.pone.0044219","article-title":"Xenogeneic graft-versus-host-disease in NOD-scid IL-2R\u03b3null mice display a T-effector memory phenotype.","volume":"7","author":"Ali","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"2019111902172485800_B23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2249.2011.04462.x","article-title":"Human peripheral blood CD4 T cell-engrafted non-obese diabetic-scid IL2r\u03b3(null) H2-Ab1 (tm1Gru) Tg (human leucocyte antigen D-related 4) mice: a mouse model of human allogeneic graft-versus-host disease.","volume":"166","author":"Covassin","year":"2011","journal-title":"Clin Exp Immunol"},{"issue":"51","key":"2019111902172485800_B24","doi-asserted-by":"crossref","first-page":"19500","DOI":"10.1073\/pnas.0604919104","article-title":"Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells.","volume":"103","author":"Maruo","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"19","key":"2019111902172485800_B25","doi-asserted-by":"crossref","first-page":"10437","DOI":"10.1128\/JVI.77.19.10437-10447.2003","article-title":"Epstein-Barr Virus nuclear protein EBNA3A is critical for maintaining lymphoblastoid cell line growth.","volume":"77","author":"Maruo","year":"2003","journal-title":"J Virol"},{"issue":"6","key":"2019111902172485800_B26","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/ajcp\/89.6.742","article-title":"Hematologic values and lymphocyte subsets in fetal blood.","volume":"89","author":"De Waele","year":"1988","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"2019111902172485800_B27","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1046\/j.1365-2249.2002.01920.x","article-title":"Phenotypic and functional analysis of human T lymphocytes in early second- and third-trimester fetuses.","volume":"129","author":"Zhao","year":"2002","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"2019111902172485800_B28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0092-8674(00)80059-8","article-title":"CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs.","volume":"99","author":"F\u00f6rster","year":"1999","journal-title":"Cell"},{"key":"2019111902172485800_B29","author":"Leung"},{"issue":"3","key":"2019111902172485800_B30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa020177","article-title":"Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.","volume":"348","author":"Zhang","year":"2003","journal-title":"N Engl J Med"},{"issue":"51","key":"2019111902172485800_B31","doi-asserted-by":"crossref","first-page":"18538","DOI":"10.1073\/pnas.0509182102","article-title":"Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+\/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer.","volume":"102","author":"Sato","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5795","key":"2019111902172485800_B32","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1129139","article-title":"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.","volume":"313","author":"Galon","year":"2006","journal-title":"Science"},{"issue":"3","key":"2019111902172485800_B33","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00262-008-0583-5","article-title":"Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer.","volume":"58","author":"Leffers","year":"2009","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"2019111902172485800_B34","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0092-8674(90)90591-2","article-title":"Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response.","volume":"60","author":"Fearon","year":"1990","journal-title":"Cell"},{"issue":"8","key":"2019111902172485800_B35","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1073\/pnas.90.8.3539","article-title":"Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.","volume":"90","author":"Dranoff","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"2019111902172485800_B36","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1038\/bjc.2014.162","article-title":"Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in glioma.","volume":"110","author":"Han","year":"2014","journal-title":"Br J Cancer"},{"issue":"5","key":"2019111902172485800_B37","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1182\/blood-2004-06-2411","article-title":"Donor CD8+ T cells facilitate induction of chimerism and tolerance without GVHD in autoimmune NOD mice conditioned with anti-CD3 mAb.","volume":"105","author":"Liang","year":"2005","journal-title":"Blood"},{"issue":"2","key":"2019111902172485800_B38","doi-asserted-by":"crossref","first-page":"838","DOI":"10.4049\/jimmunol.178.2.838","article-title":"Donor CD8+ T cells mediate graft-versus-leukemia activity without clinical signs of graft-versus-host disease in recipients conditioned with anti-CD3 monoclonal antibody.","volume":"178","author":"Zhang","year":"2007","journal-title":"J Immunol"},{"issue":"3","key":"2019111902172485800_B39","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/bbmt.1999.v5.pm10392958","article-title":"Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets.","volume":"5","author":"Johnson","year":"1999","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2019111902172485800_B40","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1182\/blood-2011-01-331009","article-title":"Distinct graft-versus-leukemic stem cell effects of early or delayed donor leukocyte infusions in a mouse chronic myeloid leukemia model.","volume":"119","author":"Lu","year":"2012","journal-title":"Blood"},{"issue":"7","key":"2019111902172485800_B41","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.4049\/jimmunol.158.7.3359","article-title":"IL-12 induces T helper 1-directed antitumor response.","volume":"158","author":"Tsung","year":"1997","journal-title":"J Immunol"},{"issue":"2","key":"2019111902172485800_B42","doi-asserted-by":"crossref","first-page":"664","DOI":"10.4049\/jimmunol.159.2.664","article-title":"Type 1 versus type 2 cytokine release by Vbeta T cell subpopulations determines in vivo antitumor reactivity: IL-10 mediates a suppressive role.","volume":"159","author":"Aruga","year":"1997","journal-title":"J Immunol"},{"issue":"3","key":"2019111902172485800_B43","first-page":"118","article-title":"Allospecific CD4+, Th1\/Th2 and CD8+, Tc1\/Tc2 populations in murine GVL: type I cells generate GVL and type II cells abrogate GVL.","volume":"2","author":"Fowler","year":"1996","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"2019111902172485800_B44","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.4049\/jimmunol.160.11.5355","article-title":"Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines.","volume":"160","author":"Blazar","year":"1998","journal-title":"J Immunol"},{"issue":"6","key":"2019111902172485800_B45","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.4049\/jimmunol.161.6.3033","article-title":"Gene-modified tumor vaccine with therapeutic potential shifts tumor-specific T cell response from a type 2 to a type 1 cytokine profile.","volume":"161","author":"Hu","year":"1998","journal-title":"J Immunol"},{"issue":"2","key":"2019111902172485800_B46","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.immuni.2004.07.017","article-title":"The immunobiology of cancer immunosurveillance and immunoediting.","volume":"21","author":"Dunn","year":"2004","journal-title":"Immunity"},{"issue":"6","key":"2019111902172485800_B47","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nri821","article-title":"CD4+ CD25+ suppressor T cells: more questions than answers.","volume":"2","author":"Shevach","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2019111902172485800_B48","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrc1586","article-title":"Immunosuppressive networks in the tumour environment and their therapeutic relevance.","volume":"5","author":"Zou","year":"2005","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"2019111902172485800_B49","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni1178","article-title":"Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self.","volume":"6","author":"Sakaguchi","year":"2005","journal-title":"Nat Immunol"},{"issue":"1","key":"2019111902172485800_B50","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/bjc.2011.189","article-title":"The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis.","volume":"105","author":"Gooden","year":"2011","journal-title":"Br J Cancer"},{"issue":"41","key":"2019111902172485800_B51","doi-asserted-by":"crossref","first-page":"41ra52","DOI":"10.1126\/scitranslmed.3001302","article-title":"CD4+CD25+ regulatory T cell depletion improves the graft-versus-tumor effect of donor lymphocytes after allogeneic hematopoietic stem cell transplantation.","volume":"2","author":"Maury","year":"2010","journal-title":"Sci Transl Med"},{"issue":"6011","key":"2019111902172485800_B52","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1126\/science.1196509","article-title":"Fetal and adult hematopoietic stem cells give rise to distinct T cell lineages in humans.","volume":"330","author":"Mold","year":"2010","journal-title":"Science"},{"issue":"8","key":"2019111902172485800_B53","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/ncb2783","article-title":"The Lin28b-let-7-Hmga2 axis determines the higher self-renewal potential of fetal haematopoietic stem cells.","volume":"15","author":"Copley","year":"2013","journal-title":"Nat Cell Biol"},{"issue":"1","key":"2019111902172485800_B54","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1182\/blood.V91.1.207","article-title":"Differential cytotoxicity of cord blood and bone marrow-derived natural killer cells.","volume":"91","author":"Gardiner","year":"1998","journal-title":"Blood"},{"issue":"7","key":"2019111902172485800_B55","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/CJI.0b013e3181e475e9","article-title":"Cord blood natural killer cells exhibit impaired lytic immunological synapse formation that is reversed with IL-2 exvivo expansion.","volume":"33","author":"Xing","year":"2010","journal-title":"J Immunother"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/126\/26\/2882\/1391141\/2882.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/126\/26\/2882\/1391141\/2882.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T03:53:34Z","timestamp":1692071614000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/126\/26\/2882\/34797\/Cord-blood-T-cells-mediate-enhanced-antitumor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,24]]},"references-count":55,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2015,12,24]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2015-06-654780","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,24]]}}}